At a glance
- Originator Abbott Laboratories
- Class Natriuretic peptides
- Mechanism of Action Diuretics
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Renal failure
Most Recent Events
- 11 Jun 1996 Discontinued-Preclinical for Renal failure in USA (Unknown route)
- 17 Oct 1994 No-Development-Reported for Renal failure in USA (Unknown route)